- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04786665
Strawberries, Cognition, and Vascular Health
May 3, 2022 updated by: Shirin Hooshmand, San Diego State University
Impact of Strawberries on Cognition, and Vascular and Cardiometabolic Markers in Older Healthy Adults
The primary objective of this study is to investigate the effects of strawberries on cognitive responses, motor control function, and vascular and cardiometabolic risk markers in healthy older adults.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
To achieve the objectives, 40 healthy men and women ≥65 years of age will consume 26 g of freeze-dried strawberries in the form of a drink-mix daily for 8 wk.
Using a randomized crossover study design, the effects will be compared to the effects of 8 wk intake of a placebo drink-mix (with a 4 wk wash-out period between trials).
Cognitive function measurements will be performed at baseline and 8 wk.
Additionally, at each timepoint, flow-mediated vasodilation and blood pressure will be measured followed by collection of fasting blood samples to assess glucose, insulin, blood lipids (free fatty acids, triacylglycerol, total cholesterol, LDL cholesterol, and HDL cholesterol), inflammatory markers (interleukins 6 and 18), and markers of oxidative stress (oxidized LDL-C and malondialdehyde).
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Diego, California, United States, 92182-7251
- Shirin Hooshmand
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy men and women 65 years and older
Exclusion Criteria:
- stroke or myocardial infarction
- neurological disorders:
- epilepsy,
- multiple sclerosis,
- Parkinson's disease,
- stroke
- known metabolic disorders:
- liver,
- renal
- clinically diagnosed diabetes
- drug treatment for lipid reduction or hypertension,
- psychiatric medication use
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Strawberry powder
Participants consume 1 package of standard strawberry powder (26 g) daily for 8 weeks
|
Freeze dried strawberry powder
|
PLACEBO_COMPARATOR: Placebo group
Participants consume 1 package of placebo powder (26 g) daily for 8 weeks
|
Comparative placebo powder
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in processing speed (cognition) at 8 weeks
Time Frame: At baseline, at 8 weeks
|
using Pattern Comparison Processing Speed Test
|
At baseline, at 8 weeks
|
Change from baseline in executive function (cognition) at 8 weeks
Time Frame: At baseline, at 8 weeks
|
using Dimensional Change Card Sort Test; Flanker Inhibitory Control and Attention Test
|
At baseline, at 8 weeks
|
Change from baseline in working memory (cognition) at 8 weeks
Time Frame: At baseline, at 8 weeks
|
using List Sorting Working Memory Test
|
At baseline, at 8 weeks
|
Change from baseline in episodic memory (cognition) at 8 weeks
Time Frame: At baseline, at 8 weeks
|
using Picture Sequence Memory Test
|
At baseline, at 8 weeks
|
Change from baseline in working memory (cognition) at 8 weeks
Time Frame: At baseline, at 8 weeks
|
using Picture Vocabulary Test; Oral Reading Recognition Test
|
At baseline, at 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in Vascular health at 8 weeks
Time Frame: At baseline, at 8 weeks
|
to better understand how changes in the gut microbiota through fruit consumption are linked to changes in health outcomes, we will assess endothelial function via flow-mediated vasodilation and risk factors for cardiometabolic dysfunction in fasting blood samples collected at baseline and after 8 weeks.
|
At baseline, at 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 30, 2019
Primary Completion (ACTUAL)
February 25, 2022
Study Completion (ACTUAL)
May 3, 2022
Study Registration Dates
First Submitted
March 3, 2021
First Submitted That Met QC Criteria
March 5, 2021
First Posted (ACTUAL)
March 8, 2021
Study Record Updates
Last Update Posted (ACTUAL)
May 5, 2022
Last Update Submitted That Met QC Criteria
May 3, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 59650A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Radboud University Medical CenterNot yet recruitingAging | Aging Well | Immuno Aging
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
Amazentis SAproDERM GmbHCompleted
-
Northumbria UniversityUniversity of East AngliaSuspendedSleep | Aging | Healthy AgingUnited Kingdom
-
University of West AtticaNot yet recruiting
-
University of Santiago de CompostelaAgencia Estatal de Investigación, SpainRecruiting
-
Beijing HospitalBGI-ShenzhenCompletedAging | Healthy Aging
Clinical Trials on Strawberry
-
Carl Ade, M.S., Ph.D.California Strawberry CommissionRecruitingObesity | Metabolic SyndromeUnited States
-
Clinical Nutrition Research Center, Illinois Institute...Completed
-
USDA Human Nutrition Research Center on AgingCalifornia Strawberry CommissionCompletedAging | Age-related Memory DisordersUnited States
-
Florida State UniversityCalifornia Strawberry CommissionCompletedCardiovascular Diseases | Vascular Diseases | HypertensionUnited States
-
Penn State UniversityCalifornia Strawberry CommissionCompletedCardiovascular DiseaseUnited States
-
Clinical Nutrition Research Center, Illinois Institute...RecruitingInflammation | Insulin Resistance | Insulin Sensitivity | Pre-diabetesUnited States
-
Georgetown UniversityPenn State UniversityCompleted
-
University of GlasgowScottish Universities Environmental Research CentreCompletedHealthyUnited Kingdom
-
University of California, DavisCalifornia Strawberry CommissionCompleted
-
Clinica Universidad de Navarra, Universidad de...CompletedLipid Profile | Hyperglycemia, Postprandial | Feeding Behaviors | Antioxidant | PostprandialSpain